Address
Email address
Phone number
Website
https://www.repligen.com/Repligen | Inspiring advances in bioprocessingOur mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide.
Name
Repligen Estonia OÜ
Registry code
14121227
VAT number
EE101911580
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
27.09.2016 (8)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
71129 - Other engineering-technical activities
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Madis Unt
| - | Board member | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 2 740 750.22 € | 390 481.73 € | 375 785.44 € | 60 |
| 2024 Q3 | 2 882 778.77 € | 287 456.61 € | 376 496.32 € | 60 |
| 2024 Q2 | 2 885 304.82 € | 11 440.7 € | 385 965.5 € | 56 |
| 2024 Q1 | 4 421 607.3 € | 345 177.26 € | 362 958.13 € | 56 |
| 2023 Q4 | 3 915 895.12 € | 309 589.09 € | 330 524.25 € | 55 |
| 2023 Q3 | 1 897 382.07 € | 298 241.81 € | 318 173.65 € | 53 |
| 2023 Q2 | 3 814 563.46 € | 378 664.36 € | 403 486.86 € | 51 |
| 2023 Q1 | 743 381.96 € | 271 197.44 € | 287 645.11 € | 49 |
| 2022 Q4 | 2 583 908.55 € | 260 335.49 € | 276 046.93 € | 47 |
| 2022 Q3 | 1 057 689.18 € | 249 563.39 € | 264 786.36 € | 48 |
| 2022 Q2 | 2 203 330.23 € | 417 590.71 € | 435 941.66 € | 45 |
| 2022 Q1 | 2 011 283.95 € | 196 195.96 € | 208 844 € | 44 |
| 2021 Q4 | 1 931 107.25 € | 176 690.4 € | 186 648.43 € | 39 |
| 2021 Q3 | 3 423 459.43 € | 199 599.06 € | 212 007.71 € | 38 |
| 2021 Q2 | 1 102 486.26 € | 164 670.85 € | 176 435.99 € | 38 |
| 2021 Q1 | 3 824 508.03 € | 176 546.01 € | 188 629.65 € | 35 |
| 2020 Q4 | 6 614 060.59 € | 2 420.56 € | 173 686.33 € | 34 |
| 2020 Q3 | 447 257.14 € | 75 094.79 € | 131 196.07 € | 37 |
| 2020 Q2 | 594 472.88 € | - | 106 552.87 € | 32 |
| 2020 Q1 | 461 158.8 € | 81 037.11 € | 107 253.62 € | 25 |
